Moneycontrol PRO
Swing Trading 101
Swing Trading 101

OPINION | Galloping medical inflation is not solely a hospital issue; it starts earlier

Treatment requires a series of steps, with hospitals coming towards the end. Systemic gaps in the chain often result in avoidable hospitalisation and extra expense 

March 05, 2026 / 09:32 IST
India’s healthcare expansion over the past decade has improved access significantly.

Hospital inflation in India is often discussed in the context of rising bed charges, surgical costs, or intensive care billing. Yet, the economic pressure associated with hospitalisation frequently begins much earlier.

Long before a patient is admitted, financial escalation can already be underway through fragmented diagnostics, delayed triage and inefficiencies embedded within primary and secondary care pathways.

Understanding hospital cost inflation requires looking beyond inpatient tariffs and examining the structural flow of patients through the healthcare system.

The rising cost context 

India’s healthcare expenditure remains high at the household level despite policy efforts to expand insurance coverage. According to data from the Ministry of Health and Family Welfare and the National Health Accounts, out-of-pocket expenditure continues to account for a significant share of total health spending.

Even with schemes such as Ayushman Bharat expanding coverage, diagnostic and outpatient costs remain largely outside comprehensive reimbursement frameworks. 

Diagnostic fragmentation and financial escalation 

In many settings, diagnostic services remain fragmented across multiple providers and facilities. Patients often move between clinics, labs, and specialist centres before reaching a final diagnosis. Each step incurs direct and indirect costs, including repeat consultations, repeated testing, travel expenses, and lost income.

This fragmentation can delay clinical clarity. Delayed or incomplete diagnostics may lead to progression of disease severity by the time hospital admission becomes necessary. When conditions are identified at a later stage, treatment options are more intensive and correspondingly more expensive.

Fragmentation also leads to duplication. When clinical records are not seamlessly shared across systems, tests are often repeated to confirm earlier findings. From an economic standpoint, duplication compounds cost inflation without necessarily improving quality of care.

Escalation timing and late-stage care 

Timing is one of the most significant contributors to hospital cost inflation. In many cases, patients enter hospitals not because conditions were inherently complex, but because early-stage management was inconsistent or delayed.

Data from NITI Aayog’s health reports highlights persistent gaps in early detection of non-communicable diseases. Conditions such as hypertension and diabetes frequently go undiagnosed until complications emerge.

When patients present with advanced symptoms, hospital admission becomes unavoidable, often requiring more expensive intervention. The escalation from outpatient management to inpatient care is rarely immediate. It unfolds gradually, influenced by awareness, affordability, access and system coordination.

Workflow gaps in primary and secondary care 

Clinical workflow structure also influences cost inflation. Primary healthcare systems are intended to function as the first line of detection and management. However, uneven infrastructure, limited resources, and capacity constraints can weaken this function in many regions.

When primary care is unable to perform sufficient first-level assessment, patients are referred upstream.

Secondary care facilities, in turn, must compensate by conducting fresh investigations or prolonged observation. By the time hospital admission occurs, the cumulative diagnostic process has already increased expenditure. This workflow friction does not result from individual decision-making alone. It is embedded within system design, reimbursement patterns, and uneven access to infrastructure.

Insurance structures and cost behaviour

Insurance coverage in India has expanded significantly in the last decade. However, claim structures often incentivise inpatient over outpatient care.

Many insurance plans provide stronger reimbursement for hospitalisation than for early diagnostic intervention. This imbalance can unintentionally contribute to hospital cost inflation. When outpatient diagnostics and preventive monitoring are not adequately covered, patients may delay testing until symptoms worsen, increasing the likelihood of admission. 

IRDAI data has consistently shown rising average claim sizes, reflecting both increased service intensity and later presentation of disease. Structural design of insurance products therefore plays a role in shaping when and how patients enter the hospital system.

Urban-Rural inequality and access costs 

Geographic variation also influences pre-admission costs. Rural and semi-urban populations may travel long distances for testing or specialist consultations. Travel costs, accommodation, lost workdays, and informal expenses add financial strain well before hospitalisation. If early evaluation is inaccessible or inconsistent, conditions may worsen by the time care is sought at tertiary facilities.

Data fragmentation and continuity gaps 

Health data continuity is another structural factor. When patient records are scattered, providers lack a comprehensive view of prior investigations and outcomes. Clinical uncertainty often leads to precautionary admissions or repeat diagnostics, both of which increase costs.

Lack of interoperability between public and private facilities exacerbates duplication.

The economics of delayed prevention 

From a systems perspective, inflation in hospital costs is often the downstream expression of upstream weaknesses. Preventable complications become expensive admissions. Treatable conditions become complex procedures. Routine monitoring gaps translate into emergency responses. The World Health Organization has repeatedly emphasized that preventive care reduces long-term health expenditure.

In the Indian context, translating that principle into practice requires addressing diagnostic fragmentation, referral inefficiencies, and reimbursement misalignment.

Hospital cost inflation cannot be viewed solely as a pricing problem. It must be examined as an outcome of how patients move through the healthcare ecosystem. 

Reframing the debate 

Public discourse often centers on hospital tariffs and private sector pricing. While these are important, the structural economics tell a broader story.

Cost inflation begins with delayed detection, incomplete workflows, and systemic fragmentation. Reducing inflationary pressure requires strengthening first-contact care, improving diagnostic continuity, and aligning incentives around early intervention.

India’s healthcare expansion over the past decade has improved access significantly. The next phase will likely require deeper attention to systems integration and clinical workflow coordination. Hospital inflation, in this sense, does not start at the admission desk. It begins earlier, within the structure of how care is accessed, processed, and escalated. Recognising this reality reframes the issue from one of pricing alone to one of systemic design.

(Ashissh Raichura, Founder & CEO, Scanbo.)

Views are personal and do not represent the stand of this publication.

Ashissh Raichura is Founder & CEO, Scanbo. Views are personal and do not represent the stand of this publication.
first published: Mar 5, 2026 09:31 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347